Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
Waldencast plc - Class A Ordinary Share (WALD)
Company Research
Source: GlobeNewswire
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced a collaboration with ProMD Health as part of the Aesthetics Leadership with Obagi’s Hyaluronic Acid (ALOHA) Program. ProMD was selected for its strong multi-location network of 17 practices and its commitment to clinical excellence, making it an ideal evaluator to rigorously examine Obagi® saypha® MagIQ™ alongside comprehensive skincare protocols across its multi-state provider base. Through this collaboration, ProMD providers will participate in a structured evaluation of MagIQ across multiple practice locations. The program combines clinical education from Obagi national educators with hands on ProMD Health injector experience. The effort combines real world evaluation with an integrated skincare approach to further evidence-based advanced injection techniq
Show less
Read more
Impact Snapshot
Event Time:
WALD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WALD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WALD alerts
High impacting Waldencast plc - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
WALD
News
- Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible YouthfulnessGlobeNewswire
- Waldencast (WALD) had its price target lowered by Telsey Advisory Group from $3.00 to $2.00. They now have a "market perform" rating on the stock.MarketBeat
- Waldencast (WALD) had its price target lowered by Canaccord Genuity Group Inc. from $4.00 to $2.00. They now have a "buy" rating on the stock.MarketBeat
- Waldencast Reports Q4 2025 and FY 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Waldencast Reports Q4 2025 and FY 2025 Financial ResultsGlobeNewswire
WALD
Sec Filings
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- WALD's page on the SEC website